Compare NVAX & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | ORC |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1995 | 2013 |
| Metric | NVAX | ORC |
|---|---|---|
| Price | $6.75 | $7.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $9.75 | $7.50 |
| AVG Volume (30 Days) | 3.3M | ★ 6.4M |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 19.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.07 | 0.57 |
| Revenue | ★ $1,064,651,000.00 | $80,187,000.00 |
| Revenue This Year | $58.91 | $82.99 |
| Revenue Next Year | N/A | $61.79 |
| P/E Ratio | ★ $3.22 | $12.79 |
| Revenue Growth | ★ 20.27 | 5.93 |
| 52 Week Low | $5.01 | $5.69 |
| 52 Week High | $11.55 | $9.01 |
| Indicator | NVAX | ORC |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 58.78 |
| Support Level | $6.36 | $7.09 |
| Resistance Level | $6.76 | $7.44 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 47.39 | 67.19 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.